Jan 12, 2022 / 11:00PM GMT
Tycho W. Peterson - JPMorgan Chase & Co., Research Division - Senior Analyst
All right. Good afternoon. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this afternoon, NanoString. Just a quick reminder, you can submit questions through the website. With that, I'll turn it over to Brad.
R. Bradley Gray - NanoString Technologies, Inc. - CEO, President & Director
Thanks for having us, Tycho, and it's great to be here. Over the next 20 minutes, I hope to do 3 things. One is reintroduce NanoString and the idea of Spatial Biology. Two is, recap a really strong finish to 2021. And three is, preview some of the exciting activities and news flow coming in 2022.
I will be making forward-looking statements, and I will refer you to our SEC filings for risk factors. Let me start with NanoString's company profile.
We're a Seattle-based provider of life science tools. Our products have delighted customers in advanced science for more than a decade. Today, we have 3 major platforms with over 5,000 peer
NanoString Technologies Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot